证券代码：301256 证券简称：华融化学 公告编号：2025-046 华融化学股份有限公司 2025年半年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华融化学股份有限公司（以下简称"公司"或"本公司"）于 2025 年 4 月 14 日召开了 2024 年年度股东大会，授权董事会制定并执行 2025 年中期利润分 配；2025 年 8 月 12 日，公司召开第二届董事会第十三次会议审议通过了 2025 年半年度权益分派方案，现将权益分派事宜公告如下： 一、董事会审议通过权益分派方案情况 1、股东大会授权下，董事会审议通过的公司 2025 年中期利润分配方案为： 以总股本 48,000 万股为基数，向全体在册股东按每 10 股派发现金股利 0.40 元人 民币（含税），合计派发现金股利 19,200,000.00 元（含税），不送股，不进行资 本公积金转增股本。本次方案经董事会审议通过之日至利润分配方案实施日，如 公司总股本发生变动，则按分配总额不变的方式实施； 2、自权益分派方案披露至实施期间公司股本总额未发生变化，分配总额固 定不变 ...

Overview - Huarong Chemical Co., Ltd. has announced a guarantee for its wholly-owned subsidiaries, with a total guarantee amount not exceeding 284 million RMB [2][17] - The guarantee includes 150 million RMB for subsidiaries with a debt-to-asset ratio of 70% or higher and 134 million RMB for those below 70% [2] Guarantee Details - Huarong Chengdu, with a debt-to-asset ratio below 70%, has been granted a guarantee of 80 million RMB, while Huarong International, with a ratio above 70%, has a guarantee of 140 million RMB [3] - As of September 11, 2025, the company has provided guarantees of 46.12425 million RMB to Huarong Chengdu and 65 million RMB to Huarong International [3] - An asset pool financing agreement was signed with Zheshang Bank, allowing for a financing limit of up to 20 million RMB, which can be shared between the two subsidiaries [3][4] Financial and Operational Context - The guarantee period for the new guarantees is three years from the debt performance deadline [4] - The total amount of guarantees provided by the company is within the limits approved by the shareholders and board of directors, with no additional approval required [5] - The company maintains control over its subsidiaries, which are currently operating normally and have the capacity to repay their debts [15][16] Cumulative Guarantee Information - As of the announcement date, the total approved guarantee amount is 284 million RMB, with actual guarantees amounting to 111.12425 million RMB, representing 64.20% of the company's latest audited net assets [17] - The actual guarantee amount is 38.27792 million RMB, accounting for 22.11% of the company's latest audited net assets [17]

Summary of Key Points Core Viewpoint - Huarong Chemical announced a total guarantee amount of 2.84 billion yuan for its subsidiaries, with actual guarantees amounting to approximately 383 million yuan, indicating significant financial commitments by the company [1]. Financial Overview - The total guarantee amount approved by the shareholders and board of directors is 2.84 billion yuan, which represents 64.2% of the company's latest audited net assets [1]. - The actual guarantee amount is approximately 383 million yuan, accounting for 22.11% of the company's latest audited net assets [1]. - As of the announcement, Huarong Chemical has a market capitalization of 5 billion yuan [1]. Revenue Composition - For the year 2024, the revenue composition of Huarong Chemical is as follows: - Chemical product production and sales: 71.24% - Supply chain management business: 27.94% - Other businesses: 0.82% [1].

华融化学股份有限公司 关于为全资子公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、担保情况概述 2025 年 2 月 24 日，华融化学股份有限公司（以下简称"公司"）第二届董 事会第十次会议和第二届监事会第九次会议审议通过了《关于为子公司提供担保 预计的议案》；2025 年 3 月 12 日，公司 2025 年第一次临时股东大会审议通过 了该议案，同意公司及子公司为子公司提供总额度不超过 284,000.00 万元的连 带责任保证额度，其中为资产负债率大于等于 70%的子公司提供不超过 150,000.00 万元的连带责任保证额度、为资产负债率小于 70%的子公司提供不超 过 134,000.00 万元的连带责任保证额度。上述额度有效期自股东大会审议通过 之日起 12 个月，在有效期内可循环使用。详见公司于 2025 年 2 月 25 日披露的 《关于为子公司提供担保预计的公告》（公告编号：2025-004）。 根据前述担保预计额度授权，华融化学（成都）有限公司（以下简称"华融 成都"）作为资产负债率低于 70%的全资子公司,其获授的 ...

Group 1 - The core viewpoint of the news highlights the recent trading performance of Huarong Chemical, which experienced a decline of 3.84% on August 27, with a trading volume of 124 million yuan [1] - On August 27, Huarong Chemical had a financing buy-in amount of 10.55 million yuan and a financing repayment of 16.95 million yuan, resulting in a net financing outflow of 6.40 million yuan [1] - As of August 27, the total balance of margin trading for Huarong Chemical was 95.94 million yuan, accounting for 1.86% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of June 30, the number of shareholders of Huarong Chemical was 20,800, a decrease of 21.30% from the previous period, while the average circulating shares per person increased by 27.07% to 23,034 shares [2] - For the first half of 2025, Huarong Chemical reported an operating income of 770 million yuan, representing a year-on-year growth of 48.32%, while the net profit attributable to the parent company was 32.88 million yuan, a decrease of 25.30% year-on-year [2] - Since its A-share listing, Huarong Chemical has distributed a total of 240 million yuan in dividends, with 216 million yuan distributed over the past three years [2]

Group 1 - The stock price of Huarong Chemical is reported at 11.43 yuan, down 0.18 yuan or 1.55% from the previous trading day [1] - The stock reached a high of 11.55 yuan and a low of 11.26 yuan during the trading session, with a trading volume of 113,500 hands and a transaction amount of 1.29 billion yuan [1] - Huarong Chemical's main business includes the research, production, and sales of chemical raw materials, which are widely used in fields such as semiconductors and disinfectants [1] Group 2 - According to the company's semi-annual report for 2025, it achieved an operating income of 770 million yuan, representing a year-on-year increase of 48.32% [1] - The net profit attributable to shareholders of the listed company was 32.8848 million yuan, a year-on-year decrease of 25.30% [1] - In terms of capital flow, Huarong Chemical experienced a net outflow of 5.6006 million yuan in main funds on that day, while there was a net inflow of 94.153 million yuan in the past five days [1]

Core Insights - Huarong Chemical reported a revenue of 769,520,237.65 yuan for the first half of 2025, representing a year-on-year increase of 48.32% [2] - The net profit attributable to shareholders of the listed company was 32,884,781.52 yuan, showing a year-on-year decline of 25.30% [2] Financial Performance - The company's revenue growth indicates strong operational performance in the first half of 2025 [2] - The decline in net profit suggests potential challenges in cost management or market conditions affecting profitability [2]

Summary of Key Points Core Viewpoint - In August 2023, 30 companies released their semi-annual reports for 2025, with 20 companies reporting year-on-year profit growth and 19 companies showing revenue growth. Notably, 17 companies experienced simultaneous growth in both net profit and revenue, while 8 companies reported declines in both metrics. The most significant profit increase was observed in Zhenlei Technology, with a staggering growth rate of 1006.99% [1]. Group 1: Company Performance - Zhenlei Technology reported a net profit of 62.32 million yuan, with a year-on-year increase of 1006.99%, and revenue of 204.87 million yuan, up 73.64% [1]. - Yangfan New Materials achieved a net profit of 23.14 million yuan, reflecting a 208.94% increase, with revenue of 47.30 million yuan, up 47.93% [1]. - Zhongke Sanhuan reported a net profit of 43.99 million yuan, a 160.82% increase, but a revenue decline of 11.17% to 292.20 million yuan [1]. - Haineng Technology's net profit reached 5.47 million yuan, up 139.03%, with revenue of 13.61 million yuan, increasing by 34.87% [1]. - Daoshi Technology reported a net profit of 230.39 million yuan, a 108.16% increase, but a revenue decline of 11.64% to 365.38 million yuan [1]. Group 2: Notable Declines - Yunzhu Technology reported a net loss of 99.94 million yuan, a decline of 262.76%, with revenue of 24.62 million yuan, down 17.66% [2]. - Guizhou Moutai's net profit was 4.54 billion yuan, an 8.89% increase, with revenue of 9.11 billion yuan, up 9.16% [1][2]. - Huajin Group reported a net loss of 98.91 million yuan, a decline of 33.15%, with revenue of 2.01 billion yuan, down 5.01% [2]. - Ganyuan Food reported a net profit of 7.46 million yuan, down 55.20%, with revenue of 944.99 million yuan, down 9.34% [2].

Summary of Key Points Core Viewpoint The announcement provides a detailed report on the fundraising activities and the usage of raised funds by Huarong Chemical Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and outlining the company's financial management practices. Fundraising Overview - The company raised a total of RMB 966 million through the issuance of 12 million shares at RMB 8.05 per share, with a net amount of RMB 901.42 million after deducting issuance costs [1]. - The company has a total of RMB 406.42 million in excess funds raised [1]. Fund Usage - In the first half of 2025, the company utilized RMB 303,800 for investment projects and earned net interest income and cash management returns of RMB 4.5773 million [2]. - As of June 30, 2025, the cumulative investment in projects amounted to RMB 123.41 million, with a remaining balance of RMB 397.52 million [2]. Fund Management - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used according to regulatory guidelines [2][3]. - A tripartite supervision agreement was signed with several banks to oversee the management and usage of the raised funds [3]. Fund Storage Status - As of June 30, 2025, three dedicated accounts for the raised funds have been closed after the completion of related projects [5]. - The company has adhered to the tripartite supervision agreements without any violations [4]. Financial Reporting - The company reported a net profit of RMB 32.88 million for the first half of 2025, with a proposed cash dividend of RMB 0.40 per share, totaling RMB 19.2 million [43][45]. - The company has made changes to its accounting estimates to better reflect its financial situation, particularly regarding expected credit losses on receivables [48][49]. Board and Supervisory Meetings - The board and supervisory meetings held on August 12, 2025, approved the half-year report and the profit distribution plan, with unanimous votes [17][36].

Group 1 - The company has approved a profit distribution plan for the first half of 2025, proposing a cash dividend of 0.40 RMB per 10 shares, totaling 19,200,000 RMB, without any stock bonus or capital reserve conversion [3][10][22] - The company reported a net profit attributable to shareholders of 32,884,781.52 RMB for the first half of 2025, with cumulative undistributed profits amounting to 307,929,235.21 RMB as of June 30, 2025 [32][34] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6] Group 2 - The company held its second board meeting on August 12, 2025, where all directors attended and unanimously approved the half-year report and profit distribution plan [8][9][19] - The company has implemented changes in accounting estimates to better reflect its financial status and operational results, particularly regarding expected credit losses on receivables [36][38][41] - The company has adhered to regulations regarding the management and use of raised funds, with a total of 901,422,251.75 RMB net raised funds as of March 16, 2022, and a remaining balance of 39,751.51 million RMB as of June 30, 2025 [50][51][56]